## DHR: Danaher Corporation - XLV: Healthcare

### Executive Summary

No thesis match: MRS_20 -0.8% below STRENGTH zone (4.0-10.0%); PEG 1.96 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($214.85)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 2, Bearish: 1)

**1. Danaher Stock (DHR) News Today: BofA Lifts Price Target to $265, Wells Fargo to $240 as 2026 Normalization Comes Into Focus**
- Source: ts2.tech | 20251215T203756 | Bullish | Relevance: 100%
- Danaher Corporation (DHR) is in the spotlight after Bank of America and Wells Fargo updated their price targets, signaling a potential "normalization year" for life sciences and diagnostics demand in 2026. BofA raised its target to $265 with a Buy rating, while Wells Fargo lifted its target to $240 maintaining an Equal-Weight rating. Analysts are focusing on 2026 as headwinds are expected to fade, with Danaher's Q3 2025 results providing a stable financial anchor.

**2. Lazard Asset Management LLC Buys 311,332 Shares of Danaher Corporation $DHR**
- Source: MarketBeat | 20251214T140811 | Bullish | Relevance: 100%
- Lazard Asset Management LLC increased its stake in Danaher Corporation (NYSE:DHR) by 10.4% in the second quarter, acquiring 311,332 additional shares to own a total of 3,315,989 shares, valued at approximately $655 million. This makes Danaher its 21st-largest holding, representing about 0.46% of its investment portfolio. Analyst sentiment for Danaher is largely positive, with a "Moderate Buy" consensus rating and a target price of $246.79, stemming from 21 buy ratings versus 4 hold ratings.

**3. Thrivent Financial for Lutherans Grows Stock Holdings in Danaher Corporation $DHR**
- Source: MarketBeat | 20251214T131157 | Somewhat-Bullish | Relevance: 100%
- Thrivent Financial for Lutherans significantly increased its stake in Danaher Corporation by 6.4%, now holding 804,750 shares valued at approximately $158.98 million. Other institutional investors like Vanguard, Price T. Rowe, and Generation Investment Management also boosted their positions, while Norges Bank initiated a new substantial holding. Despite this institutional accumulation, corporate insiders have recently been net sellers of Danaher stock.

**4. Caldwell Trust Co Acquires Shares of 4,805 Danaher Corporation $DHR**
- Source: MarketBeat | 20251216T101857 | Somewhat-Bullish | Relevance: 100%
- Caldwell Trust Co acquired 4,805 shares of Danaher Corporation (NYSE:DHR) in the second quarter, valued at approximately $949,000. This comes as other institutional investors have also adjusted their positions in Danaher, and analysts maintain a "Moderate Buy" rating with a consensus price target of $247.21 for the stock. Insider selling has also been noted, with SVP Georgeann Couchara and SVP Brian W. Ellis selling a significant number of shares recently.

**5. Reynders McVeigh Capital Management LLC Lowers Stock Position in Danaher Corporation $DHR**
- Source: MarketBeat | 20251215T124417 | Neutral | Relevance: 100%
- Reynders McVeigh Capital Management LLC decreased its stake in Danaher (NYSE:DHR) by 5.7% in Q2, now holding 214,788 shares valued at $42.43 million. Company insiders sold shares totaling approximately $6.61 million, while institutional investors collectively own 79.05% of the company's stock. Danaher reported strong Q3 earnings, exceeding analyst estimates with EPS of $1.89 and revenue of $6.05 billion, and maintains a "Moderate Buy" consensus rating from analysts with a target price of $246.79.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-15 | Wells Fargo | $240 | $230 | +4% |
| 2025-12-09 | Goldman Sachs | $265 | $0 | 0% |
| 2025-12-02 | Morgan Stanley | $270 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-15 | Wells Fargo | main | Equal-Weight |
| 2025-12-09 | Goldman Sachs | init | Buy |
| 2025-12-02 | Morgan Stanley | init | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 8 ($0.20M) |
| Sells | 10 ($75.99M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 37.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 8.6% (+0.2%)
- Blackrock Inc.: 7.4% (+0.1%)
- JPMORGAN CHASE & CO: 5.3% (+404.7%)
- State Street Corpora: 3.9% (-0.3%)
- Capital Internationa: 2.4% (+1.9%)

### Key Risks

1. Heavy insider selling: $76M sold (10 transactions in 90 days).
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.96 elevated, pricing in significant growth expectations. Forward P/E 26.7x stretched relative to 9% growth. Balance sheet: $1.4B free cash flow. Insider selling cluster ($76.0M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $160.9B |
| Beta | 0.92 |
| 52W Range | $171.00 - $258.23 |
| Short Interest | 1.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.96 |
| Forward P/E | 26.7 |
| Current P/E | 29.1 |
| YoY Growth | 9.1% |
| EPS Direction | STABLE |

### Technicals

MRS_20 weakening modestly (-0.6% over 5 days). Below STRENGTH zone by 4.8pp (needs >4.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.10x) but short-term weakness (below SMA20). MACD histogram bearish (-0.61), momentum weakening. RSI neutral at 51. OFD pattern: -MLL (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.77% (CS: 35) | Neutral |
| RSI_14 | 51.1 | Neutral |
| MACD Histogram | -0.61 | Bearish |
| vs SMA20 | 0.991x | Below |
| vs SMA50 | 1.027x | Above |
| vs SMA200 | 1.103x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $224.71
- **Stop Loss:** $214.85 (4.4% risk)
- **Target:** $234.57 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 101
- **Position Value:** $22,695.71
- **Portfolio %:** 22.70%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk positioning. VIX remains calm at 16.48 while breadth shows modest improvement to 52%, indicating neither euphoria nor distress. Mixed sectoral themes from energy weakness to AI expansion suggest stock-picking environment rather than broad directional moves.*

### Earnings

**Next:** 2026-01-28 (Est: $2.14)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.72 | $1.89 | +9.8% |
| 2025Q2 | $1.64 | $1.80 | +9.5% |
| 2025Q1 | $1.64 | $1.88 | +14.4% |
| 2024Q4 | $2.16 | $2.14 | -1.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*